Shenghong Ma
University of California San Diego(US)
Publications by Year
Research Areas
Hippo pathway signaling and YAP/TAZ, Epigenetics and DNA Methylation, Cancer, Hypoxia, and Metabolism, RNA modifications and cancer, Glioma Diagnosis and Treatment
Most-Cited Works
- → The Hippo Pathway: Biology and Pathophysiology(2018)1,392 cited
- → Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors(2012)1,097 cited
- → WT1 Recruits TET2 to Regulate Its Target Gene Expression and Suppress Leukemia Cell Proliferation(2015)303 cited
- → The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell(2018)266 cited
- → Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents(2015)198 cited
- → Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer(2022)132 cited
- → STRIPAK integrates upstream signals to initiate the Hippo kinase cascade(2019)121 cited
- → Dual-phase stimulated Raman scattering microscopy for real-time two-color imaging(2016)110 cited
- → Hippo signalling maintains ER expression and ER+ breast cancer growth(2021)86 cited
- → R-2-Hydroxyglutarate as the Key Effector of IDH Mutations Promoting Oncogenesis(2013)86 cited